In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Kestra Medical Technologies Ltd., with a price target of $27.00. The company’s shares closed last Tuesday at ...
Plasma medicine, a therapeutic technology that uses atmospheric-pressure plasma, is attracting attention as an innovative tool in medicine. It holds potential in applications ranging from wound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback